PCM
DGX icon

Parsons Capital Management’s Quest Diagnostics DGX Stock Holding History

Parsons Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Sell
7,585
-388
-5% -$75.4K 0.07% 228
2025
Q4 		$1.38M Hold
7,973
– – 0.08% 210
2025
Q3 		$1.52M Hold
7,973
– – 0.09% 198
2025
Q2 		$1.43M Hold
7,973
– – 0.09% 194
2025
Q1 		$1.35M Sell
7,973
-1,425
-15% -$234K 0.07% 213
2024
Q4 		$1.42M Sell
9,398
-225
-2% -$35K 0.08% 203
2024
Q3 		$1.49M Sell
9,623
-300
-3% -$44.8K 0.09% 190
2024
Q2 		$1.36M Sell
9,923
-45
-0.5% -$6.16K 0.09% 191
2024
Q1 		$1.33M Sell
9,968
-143
-1% -$18.6K 0.09% 196
2023
Q4 		$1.39M Sell
10,111
-485
-5% -$63.8K 0.1% 184
2023
Q3 		$1.29M Sell
10,596
-174
-2% -$23.2K 0.1% 180
2023
Q2 		$1.51M Buy
10,770
+362
+3% +$49.9K 0.12% 163
2023
Q1 		$1.47M Sell
10,408
-200
-2% -$28.6K 0.12% 164
2022
Q4 		$1.66M Buy
10,608
+100
+1% +$14.4K 0.14% 147
2022
Q3 		$1.29M Hold
10,508
– – 0.12% 164
2022
Q2 		$1.4M Buy
10,508
+4
+0% +$545 0.13% 159
2022
Q1 		$1.44M Sell
10,504
-125
-1% -$17.4K 0.11% 175
2021
Q4 		$1.84M Sell
10,629
-35
-0.3% -$5.33K 0.13% 151
2021
Q3 		$1.55M Sell
10,664
-5
-0% -$732 0.12% 166
2021
Q2 		$1.41M Sell
10,669
-121
-1% -$15.8K 0.11% 177
2021
Q1 		$1.39M Sell
10,790
-15
-0.1% -$1.85K 0.11% 173
2020
Q4 		$1.29M Hold
10,805
– – 0.11% 175
2020
Q3 		$1.24M Sell
10,805
-34
-0.3% -$4.02K 0.12% 160
2020
Q2 		$1.24M Sell
10,839
-46
-0.4% -$4.88K 0.13% 144
2020
Q1 		$874K Sell
10,885
-477
-4% -$49.4K 0.11% 162
2019
Q4 		$1.21M Sell
11,362
-500
-4% -$52.1K 0.12% 157
2019
Q3 		$1.27M Sell
11,862
-274
-2% -$28.1K 0.14% 149
2019
Q2 		$1.24M Sell
12,136
-170
-1% -$16.3K 0.13% 150
2019
Q1 		$1.11M Sell
12,306
-346
-3% -$30K 0.12% 163
2018
Q4 		$1.05M Sell
12,652
-30
-0.2% -$2.81K 0.13% 154
2018
Q3 		$1.37M Sell
12,682
-170
-1% -$18.6K 0.14% 145
2018
Q2 		$1.41M Sell
12,852
-50
-0.4% -$5.21K 0.16% 133
2018
Q1 		$1.29M Sell
12,902
-200
-2% -$20.5K 0.15% 138
2017
Q4 		$1.29M Sell
13,102
-50
-0.4% -$4.74K 0.14% 148
2017
Q3 		$1.23M Sell
13,152
-348
-3% -$36.9K 0.15% 146
2017
Q2 		$1.5M Sell
13,500
-250
-2% -$26.4K 0.18% 125
2017
Q1 		$1.35M Buy
13,750
+300
+2% +$28.6K 0.17% 134
2016
Q4 		$1.24M Buy
13,450
+175
+1% +$15.1K 0.16% 139
2016
Q3 		$1.12M Sell
13,275
-125
-0.9% -$10.5K 0.15% 150
2016
Q2 		$1.09M Buy
13,400
+375
+3% +$28.6K 0.15% 151
2016
Q1 		$931K Sell
13,025
-132
-1% -$8.85K 0.13% 170
2015
Q4 		$936K Sell
13,157
-433
-3% -$29.1K 0.13% 164
2015
Q3 		$835K Buy
13,590
+775
+6% +$54.2K 0.12% 174
2015
Q2 		$929K Buy
+12,815
New +$946K 0.12% 174
2015
Q1 		– Sell
-12,140
Closed -$815K – 600
2014
Q4 		$815K Buy
+12,140
New +$766K 0.11% 178

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Parsons Capital Management's DGX Position: Q1 2026 in Review

Parsons Capital Management reduced its Quest Diagnostics (DGX) stake by 4.9% in Q1 2026, selling an estimated $75.4K and leaving 7,585 shares worth $1.49M. The position accounts for 0.07% of the portfolio, ranked #228.

Parsons Capital Management first reported a position in DGX in Q4 2014 and has held it in 45 quarters since. The position peaked at $1.84M in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Parsons Capital Management held 7,585 shares of Quest Diagnostics worth $1.49M as of Q1 2026.
  • Parsons Capital Management sold 388 Quest Diagnostics shares in Q1 2026, an estimated $75.4K.
  • Quest Diagnostics made up 0.07% of Parsons Capital Management's portfolio in Q1 2026, its #228 holding.
  • Parsons Capital Management first reported a position in Quest Diagnostics in Q4 2014 and has held it in 45 quarters since.
  • Parsons Capital Management's Quest Diagnostics position peaked at $1.84M in Q4 2021.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Parsons Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.